Related Experiment Video
Updated: Jan 25, 2026

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Inflammasome Activation Triggers Blood Clotting and Host Death through Pyroptosis
Congqing Wu1, Wei Lu2, Yan Zhang1
1Saha Cardiovascular Research Center, College of Medicine, University of Kentucky, Lexington, KY, USA.
Abstract:
Inflammasome activation and subsequent pyroptosis are critical defense mechanisms against microbes. However, overactivation of inflammasome leads to death of the host. Although recent studies have uncovered the mechanism of pyroptosis following inflammasome activation, how pyroptotic cell death drives pathogenesis, eventually leading to death of the host, is unknown. Here, we identified inflammasome activation as a trigger for blood clotting through pyroptosis. We have shown that canonical inflammasome activation by the conserved type III secretion system (T3SS) rod proteins from Gram-negative bacteria or noncanonical inflammasome activation by lipopolysaccharide (LPS) induced systemic blood clotting and massive thrombosis in tissues. Following inflammasome activation, pyroptotic macrophages released tissue factor (TF), an essential initiator of coagulation cascades. Genetic or pharmacological inhibition of TF abolishes inflammasome-mediated blood clotting and protects against death. Our data reveal that blood clotting is the major cause of host death following inflammasome activation and demonstrate that inflammasome bridges inflammation with thrombosis.
Insights
Inflammasome activation triggers blood clotting via pyroptosis, leading to host death. Inhibiting tissue factor stops this inflammasome-driven thrombosis and protects against fatality.
Area of Science:
- Immunology
- Pathology
- Microbiology
Background:
- Inflammasomes are crucial for microbial defense but overactivation causes host death.
- Pyroptosis, a form of inflammatory cell death, follows inflammasome activation.
- The role of pyroptosis in host death and pathogenesis remains unclear.
Purpose of the Study:
- To investigate the link between inflammasome activation, pyroptosis, and host death.
- To elucidate the mechanism by which pyroptotic cell death drives pathogenesis.
- To identify inflammasome activation as a trigger for blood clotting.
Main Methods:
- Studied canonical inflammasome activation by type III secretion system (T3SS) rod proteins.
- Investigated noncanonical inflammasome activation by lipopolysaccharide (LPS).
- Analyzed pyroptotic macrophage release of tissue factor (TF) and its role in coagulation.
Main Results:
- Inflammasome activation, via T3SS or LPS, induced systemic blood clotting and thrombosis.
- Pyroptotic macrophages released TF, initiating coagulation cascades.
- Inhibiting TF abolished inflammasome-mediated clotting and protected against death.
Conclusions:
- Blood clotting is the primary cause of host death following inflammasome activation.
- Inflammasome activation bridges inflammation and thrombosis.
- Targeting TF offers a protective strategy against inflammasome-induced mortality.
Related Concept Videos
Clot Retraction and Fibrinolysis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Co-activators and Co-repressors
Blood Flow
Composition of Blood
Formed elements constitute the remaining 45% of the blood volume. These...

